Ozempic may be reshaping the brain, scientists say
New research suggests that Ozempic and similar GLP-1 drugs may not only treat diabetes and aid weight loss but also reshape brain activity, potentially reducing cravings and inflammation. Scientists are exploring how these medications affect neural pathways related to reward, addiction, and mood, opening possibilities for treating conditions beyond metabolic disorders.